CRINETICS PHARMACEUTICALS IN
CRNX·22663K107·US·Common Stock·Healthcare - Biotechnology-13D/G
CRNX (CRINETICS PHARMACEUTICALS IN) is held by 138 institutional investors as of Q1 2026. Largest holders: FMR LLC ($572.4M), BlackRock, Inc. ($308M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($302.8M). Net institutional sentiment: Bullish. In Q1 2026, 2 members of Congress and 103 funds bought CRNX.
138
Holders
(15 Elite)
$3.7B
Total Value
70% (147)
Consensus
103 buying - 44 selling
13F: Insider & Congress:
Who's Trading
InsiderVRVivaldi Coelho RogerioSell $120KJul 2, 2026
InsiderKEKnight Jeff E.Sell $3.4MApr 8, 2026
InsiderSSStruthers Richard ScottSell $490KMar 16, 2026
InsiderSSStruthers Richard ScottSell $332KMar 16, 2026
Top Holders
Showing 1-20 of 150
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer